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Abstract Objective: To explore the
consequences of helium/oxygen
(He/O2) inhalation on respiratory
mechanics, gas exchange, and venti-
lation-perfusion (VA/Q) relation-
ships in an animal model of severe
induced bronchospasm during me-
chanical ventilation. Design: Pro-
spective, interventional study. 
Setting: Experimental animal labora-
tory, university hospital. Interven-
tions: Seven piglets were anesthe-
tized, paralyzed, and mechanically
ventilated, with all ventilator settings
remaining constant throughout the
protocol. Acute stable bronchospasm
was obtained through continuous
aerosolization of methacholine. Once
steady-state was achieved, the ani-
mals successively breathed air/O2
and He/O2 (FIO2 0.3), or inversely,
in random order. Measurements were
taken at baseline, during broncho-
spasm, and after 30 min of He/O2
inhalation. Results: Bronchospasm
increased lung peak inspiratory 
pressure (49±6.9 vs 18±1 cm H2O,
P<0.001), lung resistance (22.7±1.5
vs 6.8±1.5 cm H2O.l−1.s, P<0.001),
dynamic elastance (76±11.2 vs
22.8±4.1 cm H2O.l−1, P<0.001), and
work of breathing (1.51±0.26 vs
0.47±0.08, P<0.001). Arterial pH de-
creased (7.47±0.06 vs 7.32±0.06,
P<0.001), PaCO2 increased, and
PaO2 decreased. Multiple inert gas
elimination showed an absence of
shunt, substantial increases in perfu-
sion to low VA/Q regions, and dis-
persion of VA/Q distribution. He/O2
reduced lung resistance and work 
of breathing, and worsened hyper-
capnia and respiratory acidosis. 
Conclusions: In this model, while
He/O2 improved respiratory mechan-
ics and reduced work of breathing,
hypercapnia and respiratory acidosis
increased. Close attention should be
paid to monitoring arterial blood
gases when He/O2 is used in me-
chanically ventilated acute severe
asthma.
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Introduction
Mechanical ventilation with endotracheal intubation is
required in approximately 40% of patients admitted to
the ICU for acute severe asthma (ASA) [1], and is re-
sponsible for an increase in morbidity and mortality [1,
2, 3, 4]. Barotrauma and severe hypotension resulting
from high end-inspiratory pulmonary volume and intrin-
sic PEEP [5, 6] are the most frequently observed compli-
cations in these patients [1, 3, 4]. Due to its low density,
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helium/oxygen (He/O2) reduces the resistance to flow in
the airways [7], and has been shown to improve peak in-
spiratory flow, dyspnea, and pulsus paradoxus in non-
intubated patients with ASA [8, 9], to increase arterial
pH and decrease PaCO2 in intubated and mechanically
ventilated patients [10, 11], and to improve respiratory
mechanics in a mechanically ventilated animal model
[12]. Thus, He/O2 inhalation could be included in the
management strategy of such patients. However, this ap-
proach raises some concerns. Indeed, the low density of
helium can interfere with the pneumotachograph used by
most ventilators to measure inspiratory flow and com-
pute delivered tidal volume (VT), as these devices are
normally calibrated for air/O2 [13]. In turn, this can lead
to improper tidal volume and FIO2 administration [13].
Furthermore, a worsening of hypoxemia with helium has
been documented in obstructive airway disease [14, 15].
The purpose of this study was to explore the effects of
He/O2 inhalation on respiratory mechanics, gas ex-
change, and ventilation-perfusion relationships in a re-
cently validated model of stable methacholine-induced
bronchospasm mimicking ASA in intubated and me-
chanically ventilated piglets [16].
Materials and methods
Animals
The study was conducted in the Laboratory of Experimental Sur-
gery, St.-Luc Hospital, in Brussels. The study protocol was ap-
proved by the ethics committee for animal experiments of the
Catholic University of Louvain, Brussels. Eight young piglets (age
3–4 months) were used, and at the end of each experiment were
killed using a solution of embutramide, mebenzonium iodide, and
tetracaine (T61; Intervet, Mechelen, Belgium).
Anesthesia and equipment
The animals were anesthetized with intramuscular xylazine hydro-
chloride, 2 mg.kg−1, and tiletamin/zolazepam, 7.5 mg.kg−1, fol-
lowed by intravenous propofol at a constant infusion rate of
2 mg.kg−1.h−1. Animals were placed in the supine position, intu-
bated (6.5 mm internal diameter cuffed orotracheal tube), and 
mechanically ventilated with a Servo 900C ventilator (Siemens
Elema, Solna, Sweden). Muscle paralysis throughout the experi-
ment was obtained with i.v. pancuronium bromide (0.1 mg.kg−1
bolus, followed by a 0.2 mg.kg−1.h−1 constant infusion). Invasive
blood pressure measurement and arterial blood gas sampling were
obtained with a peripheral arterial catheter. A continuous cardiac
output and mixed venous saturation pulmonary arterial catheter
(CCO-SvO2 catheter; Baxter Edwards Laboratories, Irvine, Calif.,
USA) was inserted to allow measurements of cardiac output,
blood temperature, mixed venous oxygen saturation (SvO2), and
the withdrawal of blood samples.
Mechanical ventilation and basic monitoring
Mechanical ventilation was performed in volume-controlled
mode, adjusted to obtain normocapnia with a fraction of inspired
oxygen (FIO2) of 0.3, no PEEP, and an inspiratory time of 33%
with no inspiratory plateau. All ventilatory parameters and FIO2
were kept constant during the subsequent experimental phases.
Heart rate, SpO2, end-tidal CO2, peak inspiratory pressure (PIP),
and mean inspiratory pressure were monitored.
Respiratory system mechanics
An esophageal balloon (International Medical Products, Kleve,
The Netherlands) filled with 1 cc air was connected to a
±140 cm H2O differential pressure transducer (Validyne Engi-
neering, North Ridge, Calif., USA). The balloon was positioned
to obtain a representative pleural pressure tracing according to
standard technique [17] and checked using the occlusion test 
[18]. Airflow (V˙ ) was measured by a Fleisch N°2 pneumotacho-
graph (Fleisch, Lausanne, Switzerland). Volume (V) was obtained
by electrical integration of the flow signal. The pneumotacho-
graph was calibrated by placing it in series with a dry gasometer
(Parkinson and Cowan CD4, Manchester, UK), and passing the
two gas mixtures, i.e., air/O2 70:30 and He/O2 70:30 through this
setup. A T-tube was placed between the ventilator and the pneu-
motachograph, and connected to both the other port of the pres-
sure transducer used for esophageal pressure, to measure trans-
pulmonary pressure, and to a second 140 cm H2O differential
pressure transducer, for the measurement of airway pressure.
Pressure, V˙ , and V signals were recorded on paper with a TA 11
electrostatic recorder (Gould Instruments, Valley View, Ohio,
USA), then scanned and digitalized (Un-Scan-It; Silk Scientific,
Orem, Vt., USA). Lung resistance (Rl) and dynamic elastance
(Ed) were calculated by multiple linear analysis [19] fitting of the
equation of motion:
where Ptp is the transpulmonary pressure and k is a constant. Tra-
cheal tube resistance was not subtracted from Rl.
Dynamic intrinsic PEEP (PEEPi, dyn) was measured according
to the method of Rossi et al., which assumes that the increase in
airway pressure preceding inspiratory V˙ reflects the equivalent of
pressure needed to counterbalance PEEPi [20].
Work of breathing was measured by graphical analysis of the
esophageal pressure curve [21], and normalized for the tidal vol-
ume. Fifteen respiratory cycles were analyzed during each step of
the protocol.
Ventilation-perfusion (VA/Q) relationship
The measurements of the distribution of the VA/Q ratios were per-
formed according to the multiple inert gas elimination technique
(MIGET) [22]. Six inert gases of different solubilities (SF6, eth-
ane, cyclopropane, halothane, ether, and acetone) equilibrated in
0.9% NaCl were infused at a constant rate of 3 ml min−1 through a
central venous catheter (the Swan-Ganz introducer). After an
equilibration period of 30 min, double 10 ml blood samples from
the peripheral artery and 5 ml blood samples from the pulmonary
artery were taken into heparinized 20-ml glass syringes. Samples
of mixed expired gas were collected from the exhaust port of the
ventilator into 50-ml gas-tight syringes (Hamilton 50 TLL; Hamil-
ton, Reno, Nev., USA). Inert gas concentrations were determined
with a gas chromatograph (Perkin Elmer, Shelton, Conn., USA)
equipped with an electron capture detector for SF6 and a flame
ionization detector for the other five gases. For each gas, retention
(ratio of arterial to mixed venous concentration) and excretion 
(ratio of mixed expired air to mixed venous concentration) were
calculated. The continuous distribution of blood flow and ventila-
tion against the VA/Q ratios from these data were calculated by
the computer program of Evans and Wagner [23].
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Methacholine challenge
The detailed method for performing the methacholine challenge has
been described and validated in a previous study [16]. In brief, a
synchronized nebulizer (ServoNebulizer 945; Siemens Elema) was
connected to the ventilator’s inspiratory circuit. Peak inspiratory
pressure was continuously observed, methacholine was aerosolized,
and its concentration was adjusted to obtain an increase in PIP up to
±40 cm H2O. Subsequently, adjustments of methacholine concentra-
tion were performed as needed to stabilize the level of broncho-
spasm, stability being defined as a variation of PIP <5% over
15 min. Results from our previous validation study [16] showed that,
once achieved, steady-state lasted for approximately 60 min without
the need for further adjustments in methacholine concentration.
Measurement protocol
A complete set of all measurements described above were per-
formed at the following time points:
1. Immediately prior to initiating the methacholine aerosoliza-
tions (air/O2 baseline)
2. After induction of the bronchospasm, once steady-state was
achieved (68±9 min, mean ± SD)
3. In random order:
– After 30 min of air/O2 breathing followed by 30 min of
He/O2 breathing
– After 30 min of He/O2 breathing followed by 30 min of
He/O2 breathing
Since no statistically significant difference was noted between
air/O2 measurements during bronchospasm, results are reported as
air/O2 baseline, air/O2 bronchospasm, and He/O2 bronchospasm.
Statistical methods
Values reported in the results are expressed as mean ± SD. A one-
way analysis of variance (ANOVA) for repeated measures was used
to compare the values obtained at each of the three protocol condi-
tions. A P value <0.05 was considered significant. Statistics were
computed using Systat 8.0 software (SPSS, Chicago, Ill., USA).
Results
Nine piglets (body weight 54.6±14.6 kg) were used in
the study. One animal was excluded due to the presence
of severe hypoxemia at baseline suggesting pre-existing
lung disease, and another was lost during induction of
anesthesia. The seven other animals completed the study
successfully. Bronchospasm led to a marked increase in
peak inspiratory pressure, lung resistance, and dynamic
elastance, lung resistance being lowered by He/O2 (Ta-
ble 1). Minute ventilation remained unchanged during all
three phases, while work of breathing increased substan-
Table 1 Ventilatory parameters
and hemodynamics. Results are
expressed as mean ± SD. 
(Rl Lung resistance, Ed dynam-
ic elastance, Cd dynamic com-
pliance, PEEPi, dyn dynamic
intrinsic positive end-expirato-
ry pressure, WOB work of
breathing, VE minute ventila-
tion, PIP peak inspiratory pres-
sure, CO cardiac output,
HR heart rate, MAP mean arte-
rial pressure, PAP mean pulmo-
nary arterial pressure)
Baseline Bronchospasm Bronchospasm
Air/O2 He/O2
Rl (cm H2O.l−1.s) 6.7±1.3 22.7±6* 16.5±3.7*, ***
Ed (cm H2O.l−1) 22.8±4.1 76.1±11.2** 71.1±13.1**
Cd (l.cm H2O−1) 0.045±0.008 0.013±0.002** 0.015±0.003**
PEEPi, dyn (cmH2O) 0.5±0.5 3.1±0.7* 2.4±1.1
WOB (J.l−1) 0.47±0.08 1.51±0.26* 1.18±0.14*, ***
VE (l.min−1) 9.0±1.0 9.0±1.0 8.0±1.0
PIP (cm H2O) 18±1 49±6** 44±4**
CO (l.min−1) 6.1±1.3 5.5±1.4 5.8±0.9
HR (beats.min−1) 96±19 116±24 102±15
MAP (mm Hg) 125±13 95±24 96±29
PAP (mm Hg) 22±10 33±12* 36±12*
*P<0.05 versus baseline; **P<0.001 versus baseline; ***P<0.05 versus bronchospasm air/O2
Fig. 1 Respiratory mechanics. Individual values of log standard
deviations of perfusion (Log SDQ, upper panel) and ventilation
(Log SDV, middle panel), and percent perfusion to low V/Q re-
gions (lower panel) in the three conditions studied
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tially during bronchospasm, also being reduced by
He/O2 (Table 1). Arterial pH decreased and PaCO2 in-
creased during bronchospasm, both being further wors-
ened by He/O2, while bronchospasm-induced hypoxemia
remained constant with He/O2 (Table 2). No significant
hemodynamic modifications other than a rise in pulmo-
nary arterial pressure were noted (Table 1).
Results of the MIGET analysis are summarized in
Fig. 1 and Table 2. As can be seen, the main ventilation
abnormalities were an increase in the mean, log SD, and
deadspace during bronchospasm, which remained un-
changed with He/O2. Perfusion data show a decrease in
the mean and increase in the log SD during broncho-
spasm, the latter being further increased with He/O2,
while shunt was not significantly modified, although
there was a trend towards its increase with He/O2(Table 2).
Tracings of two representative animals are shown in
Fig. 2.
Discussion
The main findings of the present study are that: (1) acute
bronchospasm led to a considerable increase in peak in-
spiratory pressure, lung resistance, and dynamic elas-
tance, as well as hypoxemia due to decreased mean per-
fusion index and increased distribution of perfusion dis-
persion, and respiratory acidosis due to hypercapnia re-
sulting from increased deadspace, and (2) He/O2, while
reducing lung resistance and work of breathing, wors-
ened the dispersion of perfusion distribution, as well as
hypercapnia and respiratory acidosis.
Let us first discuss the limitations of the study. First,
the stability of such a model must be questioned. In a
previous study, we demonstrated that continuously aero-
solized doses of methacholine, such as administered in
the present study, could lead to a stable and prolonged
bronchospastic state, allowing repeated measurements
over time, including MIGET [16], without the adverse
hemodynamic effects of intravenous administration [24].
Furthermore, the modifications of respiratory mechanics,
blood gases, and VA/Q indices observed in our previous
and present studies were similar, underlining the good
reproducibility of the model. Second, the validity of the
Fig. 2 Multiple inert gas elimination technique (MIGET). Ventila-
tion (white dots) and perfusion (black dots) distribution in two
representative animals in the three conditions studied. S Shunt, Ds
deadspace
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model in reproducing the conditions of mechanically
ventilated ASA should be addressed. The changes we
observed were comparable to those documented in other
studies, with respect to arterial blood gases and VA/Q
abnormalities [25, 26, 27] as well as respiratory mechan-
ics [28]. Third, due to the complexity of the manipula-
tions and explorations, the number of animals was small,
leading to the possibility of a type II error. Finally,
He/O2 can interfere with various aspects of ventilator
function, which can lead to changes in minute ventilation
and administered FIO2 [13]. However, reliable and stable
He/O2 administration with the machine used in these ex-
periments has been demonstrated, provided the appropri-
ate correction factors are used [13].
The alterations of respiratory mechanics witnessed in
the present study, i.e., increase in lung resistance and 
dynamic elastance during bronchospasm, are typical of
observations made in two animal models [12, 28] as 
well as studies in humans [29, 30]. In a porcine model 
of methacholine-induced bronchospasm, Orsini et al.
showed that He/O2 inhalation reduced resistance and
elastance [12], whereas only resistance was improved in
our study. Airway resistance is expected to decrease dur-
ing He/O2 inhalation due to two mechanisms. First, the
lower density of the mixture reduces Reynold’s number,
thereby increasing the likelihood of laminar flow condi-
tions, in which the relationship between driving pressure
and flow is linear as opposed to nonlinear in turbulent
flow conditions [7, 31]. Second, in areas where turbulent
flow conditions prevail, the driving pressure required to
obtain a given flow is reduced as density is decreased [7,
31]. Hence, both factors combine to reduce airway resis-
tance to flow, a commonly observed manifestation of
He/O2 inhalation, both in normal subjects [32] and ob-
structive lung disease [33]. Increased elastance in asthma
is thought to result from dynamic hyperinflation due to
incomplete end-expiratory lung emptying [5, 6]. Our re-
sults show a nonsignificant trend towards elastance re-
duction. These findings could be explained by other fac-
tors contributing to computed elastance, such as chest
wall or abdominal modifications, to insufficient time of
He/O2 administration for more complete lung emptying
to occur, or to a type II error. Regarding the former, no
apparent cause was detected during the experiments, but
specific measurements of intra-abdominal pressure or
partitioning of respiratory mechanics were not per-
formed, thus not allowing to rule out this hypothesis
completely. The duration of 30 min of He/O2 inhalation
is consistent with the study by Orsini et al., in which
elastance was significantly reduced by helium, although
the model was designed differently from ours [12]. Un-
fortunately, even though PEEPi was not significantly re-
duced, no measurement of end-expiratory volume was
performed, thus precluding a definite answer as to the
possibility of incomplete lung emptying in our model.
Hypoxemia and hypercapnia are well known manifes-
tations of ASA, and are in line with findings of other 
investigators [10, 11]. In the study by Gluck et al., intu-
bated and mechanically ventilated patients with status
asthmaticus exhibiting hypercapnia with respiratory aci-
dosis markedly improved both pH and PaCO2 after
20 min of He/O2 inhalation [11]. In the present study,
however, He/O2 tended to worsen both these parameters.
One possible explanation rests in the high deadspace
documented in the MIGET exploration, both at baseline
and in the two experimental conditions. Such a high
baseline deadspace was also present in our validation
study [16], and is mainly the result both from anatomical
and instrumental deadspace. For He/O2 to correct hyper-
capnia, the latter should mostly result from two causes:
(1) alveolar hypoventilation due to a fall in tidal volume
resulting from severe bronchospasm, the pressure limit
Table 2 Arterial blood gases
and MIGET results. Results are
expressed as mean ± SD.
(DISP R-E* Index of disper-
sion of ventilation/perfusion 
ratios, corrected for deadspace,
Q˙ T pulmonary blood flow,
V˙A/Q˙  ventilation to perfusion
ratio, VE minute ventilation,
LogSDQ˙ log standard deviation
of perfusion and ventilation
distribution, RSS residual sum
of squares)
Baseline Bronchospasm Bronchospasm
Air/O2 He/O2
PH 7.49±0.06 7.33±0.08** 7.27±0.11**, ***
PaO2/FIO2 (mm Hg) 473±60 160±33** 150±35**
PaCO2 (mm Hg) 41±6 58±10** 64±16*
Perfusion
Shunt (%Q˙ T) 3.6±3.6 0.3±0.7 5.1±6.8
0.005<V˙A/Q˙ <0.01 (%Q˙ T) 0.0±0.0 0.3±0.8 6.8±7.7
Mean % Q˙ (l.min−1) 0.58±0.14 0.16±0.12** 0.18±0.14**
LogSDQ˙ 0.45±0.11 1.41±0.24** 1.87±0.19**, ***
Ventilation
Dead space (%VE) 54.4±6.4 61.8±6.9* 58.9±3.9
10<V˙A/Q˙ <100 (%VE) 0.1±0.2 0.1±0.3 3.5±7.7
Mean V˙ (l.min−1) 0.72±0.20 1.72±0.55* 2.59±1.94
LogSDV˙ 0.45±0.08 1.14±0.20** 0.98±0.30**, ***
DISP R-E* 4.67±1.82 28.70±8.12** 30.37±8.55**
RSS 3.99±1.85 4.73±1.78 3.21±1.40
*P<0.05 versus baseline
**P<0.001 versus baseline
***P<0.05 versus broncho-
spasm air/O2
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on the ventilator being reached before the preset tidal
volume is delivered [11], and (2) deadspace resulting
from high levels of hyperinflation [34]. In both these 
instances, He/O2, by decreasing airway resistance and
hyperinflation [35], should increase alveolar ventilation
and reduce deadspace, which should in turn decrease
PaCO2. Regarding the first point, ventilator parameters
were not modified, and minute ventilation remained un-
changed during all three phases of the protocol (Table 1).
As for deadspace, no modification was noted with He/O2(Table 2). However, there was a marked increase in the
dispersion of VA/Q ratios (Disp R-E), during broncho-
spasm, which remained elevated during He/O2 inhalation(Table 2). Thus, it seems that the absence of improve-
ment of PaCO2 with He/O2 probably resulted from fail-
ure of the latter to correct this major increase in Disp 
R-E (Table 2). The reasons for this absence of improve-
ment is not obvious at this time.
The absence of change of PaO2 with He/O2 was proba-
bly the result of several factors. Hypoxemia in patients
with ASA has been shown to result from an abnormally
elevated dispersion of pulmonary blood flow distribution
with an increase in perfusion to low VA/Q units, in the ab-
sence of shunt [36, 37]. In our study, the dispersion of the
perfusion distribution was markedly increased by bron-
chospasm, and was further worsened by He/O2 (Table 2),
which should have worsened PaO2. Furthermore, even
though statistically nonsignificant, there was a trend to-
wards an increase in shunt with He/O2, which should also
have lowered PaO2. The cause for this remains specula-
tive, but some derecruitment with He/O2 could have oc-
curred, a hypothesis we are presently investigating in the
same model. Nonetheless, the effects of gas density on
convective and diffusive gas transport in the lungs are
quite complex [38], and conflicting results have emerged
regarding He/O2. He/O2 has been shown to increase PaO2
and reduce the alveolar-arterial PO2 difference (DA-aO2)
in animal studies [39], while the opposite was documented
in COPD patients [14, 15]. In two studies in COPD, one
during noninvasive ventilation [40], the other in intubated,
paralyzed, and mechanically ventilated COPD patients
[35], no effect on PaO2 was observed. Finally, in a recent
study in intubated and mechanically ventilated patients
with ASA, He/O2 reduced DA-aO2 and increased PaO2
[41]. Thus, the difficulty of extrapolating from animal da-
ta notwithstanding, it seems that He/O2 does not markedly
deteriorate arterial oxygenation in this situation, due to the
probable interaction of opposing mechanisms.
In conclusion, the results of this study show that, in a
stable animal model of methacholine-induced broncho-
spasm, He/O2 exerts favorable effects on airway resis-
tance and work of breathing, but fails to improve PEEPi,
arterial blood gases, and VA/Q relationships. Further
studies should be conducted in this model to determine
the mechanisms underlying these effects, and to explore
whether they can be extrapolated to the clinical setting.
Indeed, in intubated and mechanically ventilated patients
with acute severe asthma, avoidance of lung damage by
reducing intrathoracic pressures with He/O2 still remains
an attractive option, whose favorable effects could out-
weigh what appears to be a moderate price to pay in
terms of gas exchange.
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